The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant
By A Mystery Man Writer
The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant
Characterization of p95HER2/611CTF-positive breast cancers and
A novel HSP90 inhibitor SL-145 suppresses metastatic triple
Cancers, Free Full-Text
Characterization of CTFs from BT474 cells and breast cancer
Biomolecules, Free Full-Text
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab
Biomolecules, Free Full-Text
Cancers, Free Full-Text
